8 patents
Utility
Nitrogen-containing heteroaryl compounds and methods of use thereof
25 Jan 22
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
Michael P. Arend, Lee A. Flippin, Volkmar Guenzler-Pukall, Wen-Bin Ho, Eric D. Turtle, Xiaohui Du
Filed: 13 Mar 20
Utility
Enhanced erythropoiesis and iron metabolism
23 Feb 21
The present invention relates to methods and compounds for regulating or enhancing erthropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.
Stephen J Klaus, Al Y. Lin, Thomas B. Neff, Volkmar Guenzler-Pukall, Qingjian Wang, Lee A. Flippin, Michael P. Arend
Filed: 30 Jan 18
Utility
Enhanced erythropoiesis and iron metabolism
19 Jan 21
The present invention relates to methods and compounds for regulating or enhancing erthropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.
Stephen J. Klaus, Christopher J Molineaux, Thomas B Neff, Volkmar Guenzler-Pukall, Robert C. Stephenson, Todd W. Seeley, Ingrid Langsetmo Parobok
Filed: 27 Apr 17
Utility
Enhanced erythropoiesis and iron metabolism
4 Jan 21
The present invention relates to methods and compounds for regulating or enhancing erythropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.
Stephen J Klaus, Christopher J Molineaux, Thomas B Neff, Volkmar Guenzler-Pukall, Robert C Stephenson, Todd W Seeley, Ingrid Langsetmo Parobok
Filed: 28 Jan 18
Utility
Pharmaceutical formulations of a HIF hydroxylase inhibitor
7 Sep 20
The present disclosure relates to pharmaceutical formulations of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid and methods of use thereof.
David Conca, Lee Allen Flippin, Scott David Leigh, Claudia Witschi, Lee Robert Wright
Filed: 12 Jul 18
Utility
Nitrogen-containing heteroaryl compounds and methods of use thereof
11 May 20
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
Michael P. Arend, Lee A. Flippin, Volkmar Guenzler-Pukall, Wen-Bin Ho, Eric D. Turtle, Xiaohui Du
Filed: 21 Aug 18
Utility
Enhanced erythropoiesis and iron metabolism
20 Apr 20
The present invention relates to methods and compounds for regulating or enhancing ethropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.
Stephen J. Klaus, Christopher J Molineaux, Thomas B Neff, Volkmar Guenzler-Pukall, Robert C. Stephenson, Todd W. Seeley, Ingrid Langsetmo Parobok
Filed: 16 Apr 17
Utility
Methods for treating idiopathic pulmonary fibrosis
10 Feb 20
The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies.
Seth Porter, John L. Stauffer
Filed: 4 Jul 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first